HbA1c Advanced Clinical Chemistry Diabetes Assay

An accurate, efficient aid for the diagnosis and monitoring of diabetes mellitus

Experience convenience with the fully automated and precise HbA1c Advanced clinical chemistry assay, available on DxC 700 AU clinical chemistry analyzers. The fully automated HbA1c Advanced hemoglobin assay kit eliminates the need for manual sample pre-treatment so you deliver results with greater ease and less risk of error.

The hemoglobin assay is intended to be used as an aid for diagnosing diabetes mellitus, monitoring long-term glucose control in individuals with diabetes mellitus and for identifying patients who may be at risk of developing diabetes mellitus.

This product may not be available in your country or region at this time. Please contact your Beckman Coulter sales representative or distributor for more information.

Benefits of the HbA1c Advanced Hemoglobin Assay  

According to the World Health Organization, more than 400 million people live with diabetes worldwide, and that number may continue to rise.1 To address this critical population health concern, mid- to high-volume laboratories need a modern HbA1c clinical chemistry assay that is simple to install, operate and integrate with their existing testing workflows. With HbA1c Advanced, you can avoid the inconvenience and expense associated with additional dedicated HbA1c analyzers by opting for precision, efficiency, convenience and value.

HbA1c Advanced delivers clinical precision
Provide precise, clinically relevant results for diagnosing and monitoring diabetes.

  • Is National Glycohemoglobin Standardization Program-certified (NGSP) and Diabetes Control Complications Trial-standardized (DCCT) 
  • Improves reproducibility by eliminating operator-to-operator sample preparation variability through specific instrument and software design 

Enhanced performance
Deliver valuable clinical insights, reliably, to support more accurate diagnosis and monitoring of suspected and confirmed diabetic patients.

  • Clinically insignificant interference of common hemoglobin variants to reduce risk of missed or misdiagnosis
  • Offers total assay imprecision of ≤2% CV for greater confidence in results
  • Advanced pipetting technique to ensure homogeneous sample pickup and delivery 

Greater efficiency
Improve the HbA1c turnaround time for your mid- to high-volume laboratory with fully automated whole-blood analysis.

  • Fully automates whole-blood testing with no manual pre-treatment required
  • Integrate whole blood testing with your routine and stat samples 

Improved productivity
Streamline workflows and focus your laboratory on contributing to better patient care, not routine tasks and maintenance.

  • Extends value of reagents with onboard kit stability of 30 days and calibration stability of 15 days 
  • Eliminates extra washings with targeted cleaning of cuvettes and probes
  • Uses liquid, ready-to-use, all-inclusive reagent kits to reduce reagent management time and steps

Test principle
Advanced assay involves the use of three reagents: 

  • Total hemoglobin (THb)
  • HbA1c
  • Hemolyzing reagent

The DxC 700 AU clinical chemistry analyzer automatically performs whole-blood hemolysis by delivering whole-blood sample and hemolyzing reagent in a cuvette. The hemolyzed whole blood is then added to both the THb and HbA1c reagent cuvettes for analysis. 

THb is determined by a colorimetric method and HbA1c is determined by a turbidimetric immunoinhibition method. 

THb and HbA1c concentrations are used in the calculation of the reported HbA1c/THb ratio, which is expressed either as mmol/mol (IFCC) or % (DCCT/NGSP).
HbA1c on the  the DxC 700 AU clinical chemistry analyzer comprehensive assay menu

Announcement Experience the Benefits of Next-generation Clinical Chemistry

Get the right results at the right time with one system. The DxC 700 AU clinical chemistry analyzer is the latest innovation in a line of reliable chemistry analyzers for the mid- to high-volume laboratory. Combining the best-loved (and time-tested) features of the popular DxC and AU series of clinical chemical analyzers, this powerful analyzer delivers maximal uptime, high reliability and precise performance.

Learn more
HbA1c Datasheet

Data Sheet Critical Clinical Insights into Diabetes without the Hassle of Pre-Treatment

Provide the insights clinicians need to diagnose and monitor diabetes with confidence and without the cost and inefficiency of a dedicated analyzer. See how the HbA1c Advanced assay exclusively available on the DxC 700 AU analyzer performed in a rigorous study following CLSI EP05-A3 guidelines.

1WHO. “World Diabetes Day 2018.” https://www.who.int/diabetes/world-diabetes-day-2018/en. Accessed on 20 Dec 2018.